Apo-Sildenafil

Nazione: Nuova Zelanda

Lingua: inglese

Fonte: Medsafe (Medicines Safety Authority)

Principio attivo:

Sildenafil citrate 28.1mg equivalent to sildenafil 20mg

Commercializzato da:

Apotex NZ Ltd

INN (Nome Internazionale):

Sildenafil citrate 28.1 mg (equivalent to sildenafil 20mg)

Dosaggio:

20 mg

Forma farmaceutica:

Film coated tablet

Composizione:

Active: Sildenafil citrate 28.1mg equivalent to sildenafil 20mg Excipient: Colloidal silicon dioxide Croscarmellose sodium Hyprolose Hypromellose Macrogol 8000 Magnesium stearate Microcrystalline cellulose Titanium dioxide

Confezione:

Blister pack, Al/PVC, 90 tablets

Classe:

Prescription

Tipo di ricetta:

Prescription

Prodotto da:

Signa SA de CV

Indicazioni terapeutiche:

APO-SILDENAFIL 20 mg is used to treat patients with symptom-limited pulmonary arterial hypertension (Group I of the WHO classification of pulmonary hypertension) to improve exercise capacity. The efficacy of APO-SILDENAFIL has not been evaluated in patients currently on bosentan therapy.

Dettagli prodotto:

Package - Contents - Shelf Life: Blister pack, Al/PVC - 90 tablets - 36 months from date of manufacture stored at or below 30°C - Bottle, plastic, HDPE with blue cap and induction seal - 90 tablets - 36 months from date of manufacture stored at or below 30°C

Data dell'autorizzazione:

2011-08-10